+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Biochips Market Research Report by Fabrication Technology (Microarrays and Microfluidics), by Type (Arrays, DNA Chips, and Lab-On-A-Chip), by Application, by End User, by State - United States Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 5122010
  • Report
  • September 2021
  • Region: United States
  • 74 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The United States Biochips Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Biochips Market.

Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Biochips to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Fabrication Technology, the Biochips Market was studied across Microarrays and Microfluidics.
  • Based on Type, the Biochips Market was studied across Arrays, DNA Chips, Lab-On-A-Chip, and Protein Chips. The Arrays is further studied across Cell Arrays and Tissue Arrays.
  • Based on Application, the Biochips Market was studied across Agricultural Biotechnology, Cancer Diagnosis & Treatment, Clinical Diagnostics, DNA Chip Applications, Diagnostics, Drug Discovery, Expression Profiling, Gene Expression, Genomics, High-Throughput Screening, IVD & POC, Proteomics, and SNP Genotyping.
  • Based on End User, the Biochips Market was studied across Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, and Hospitals & Diagnostics Centers.
  • Based on State, the Biochips Market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biochips Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Biochips Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Biochips Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Biochips Market?
4. What is the competitive strategic window for opportunities in the United States Biochips Market?
5. What are the technology trends and regulatory frameworks in the United States Biochips Market?
6. What is the market share of the leading vendors in the United States Biochips Market?
7. What modes and strategic moves are considered suitable for entering the United States Biochips Market?
Note: Product cover images may vary from those shown
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Fabrication Technology Outlook
3.4. Type Outlook
3.5. Application Outlook
3.6. End User Outlook
3.7. State Outlook
3.8. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges

6. Biochips Market, by Fabrication Technology
6.1. Introduction
6.2. Microarrays
6.3. Microfluidics

7. Biochips Market, by Type
7.1. Introduction
7.2. Arrays
7.2.1. Cell Arrays
7.2.2. Tissue Arrays
7.3. DNA Chips
7.4. Lab-On-A-Chip
7.5. Protein Chips

8. Biochips Market, by Application
8.1. Introduction
8.2. Agricultural Biotechnology
8.3. Cancer Diagnosis & Treatment
8.4. Clinical Diagnostics
8.5. DNA Chip Applications
8.6. Diagnostics
8.7. Drug Discovery
8.8. Expression Profiling
8.9. Gene Expression
8.10. Genomics
8.11. High-Throughput Screening
8.12. IVD & POC
8.13. Proteomics
8.14. SNP Genotyping

9. Biochips Market, by End User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Biotechnology & Pharmaceutical Companies
9.4. Hospitals & Diagnostics Centers

10. California Biochips Market
10.1. Introduction

11. Florida Biochips Market
11.1. Introduction

12. Illinois Biochips Market
12.1. Introduction

13. New York Biochips Market
13.1. Introduction

14. Ohio Biochips Market
14.1. Introduction

15. Pennsylvania Biochips Market
15.1. Introduction

16. Texas Biochips Market
16.1. Introduction

17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis
17.3. Market Share Analysis, By Key Player
17.4. Competitive Scenario
17.4.1. Merger & Acquisition
17.4.2. Agreement, Collaboration, & Partnership
17.4.3. New Product Launch & Enhancement
17.4.4. Investment & Funding
17.4.5. Award, Recognition, & Expansion

18. Company Usability Profiles

19. Appendix
19.1. Discussion Guide
19.2. License & Pricing

List of Figures
FIGURE 1. UNITED STATES BIOCHIPS MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. UNITED STATES BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2020 (USD MILLION)
FIGURE 3. UNITED STATES BIOCHIPS MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 4. UNITED STATES BIOCHIPS MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 5. UNITED STATES BIOCHIPS MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 6. UNITED STATES BIOCHIPS MARKET SIZE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 7. UNITED STATES BIOCHIPS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 8. UNITED STATES BIOCHIPS MARKET: MARKET DYNAMICS
FIGURE 9. UNITED STATES BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2020 VS 2026 (%)
FIGURE 10. UNITED STATES BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2020 VS 2026 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2026
FIGURE 12. UNITED STATES BIOCHIPS MARKET SIZE, BY MICROARRAYS, 2018-2026 (USD MILLION)
FIGURE 13. UNITED STATES BIOCHIPS MARKET SIZE, BY MICROARRAYS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 14. UNITED STATES BIOCHIPS MARKET SIZE, BY MICROFLUIDICS, 2018-2026 (USD MILLION)
FIGURE 15. UNITED STATES BIOCHIPS MARKET SIZE, BY MICROFLUIDICS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 16. UNITED STATES BIOCHIPS MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 17. UNITED STATES BIOCHIPS MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES BIOCHIPS MARKET SIZE, BY TYPE, 2026
FIGURE 19. UNITED STATES BIOCHIPS MARKET SIZE, BY ARRAYS, 2018-2026 (USD MILLION)
FIGURE 20. UNITED STATES BIOCHIPS MARKET SIZE, BY ARRAYS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 21. UNITED STATES BIOCHIPS MARKET SIZE, BY CELL ARRAYS, 2018-2026 (USD MILLION)
FIGURE 22. UNITED STATES BIOCHIPS MARKET SIZE, BY CELL ARRAYS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 23. UNITED STATES BIOCHIPS MARKET SIZE, BY TISSUE ARRAYS, 2018-2026 (USD MILLION)
FIGURE 24. UNITED STATES BIOCHIPS MARKET SIZE, BY TISSUE ARRAYS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 25. UNITED STATES BIOCHIPS MARKET SIZE, BY DNA CHIPS, 2018-2026 (USD MILLION)
FIGURE 26. UNITED STATES BIOCHIPS MARKET SIZE, BY DNA CHIPS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 27. UNITED STATES BIOCHIPS MARKET SIZE, BY LAB-ON-A-CHIP, 2018-2026 (USD MILLION)
FIGURE 28. UNITED STATES BIOCHIPS MARKET SIZE, BY LAB-ON-A-CHIP, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 29. UNITED STATES BIOCHIPS MARKET SIZE, BY PROTEIN CHIPS, 2018-2026 (USD MILLION)
FIGURE 30. UNITED STATES BIOCHIPS MARKET SIZE, BY PROTEIN CHIPS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 31. UNITED STATES BIOCHIPS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 32. UNITED STATES BIOCHIPS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES BIOCHIPS MARKET SIZE, BY APPLICATION, 2026
FIGURE 34. UNITED STATES BIOCHIPS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2026 (USD MILLION)
FIGURE 35. UNITED STATES BIOCHIPS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 36. UNITED STATES BIOCHIPS MARKET SIZE, BY CANCER DIAGNOSIS & TREATMENT, 2018-2026 (USD MILLION)
FIGURE 37. UNITED STATES BIOCHIPS MARKET SIZE, BY CANCER DIAGNOSIS & TREATMENT, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 38. UNITED STATES BIOCHIPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2026 (USD MILLION)
FIGURE 39. UNITED STATES BIOCHIPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 40. UNITED STATES BIOCHIPS MARKET SIZE, BY DNA CHIP APPLICATIONS, 2018-2026 (USD MILLION)
FIGURE 41. UNITED STATES BIOCHIPS MARKET SIZE, BY DNA CHIP APPLICATIONS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 42. UNITED STATES BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, 2018-2026 (USD MILLION)
FIGURE 43. UNITED STATES BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 44. UNITED STATES BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2026 (USD MILLION)
FIGURE 45. UNITED STATES BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 46. UNITED STATES BIOCHIPS MARKET SIZE, BY EXPRESSION PROFILING, 2018-2026 (USD MILLION)
FIGURE 47. UNITED STATES BIOCHIPS MARKET SIZE, BY EXPRESSION PROFILING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 48. UNITED STATES BIOCHIPS MARKET SIZE, BY GENE EXPRESSION, 2018-2026 (USD MILLION)
FIGURE 49. UNITED STATES BIOCHIPS MARKET SIZE, BY GENE EXPRESSION, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 50. UNITED STATES BIOCHIPS MARKET SIZE, BY GENOMICS, 2018-2026 (USD MILLION)
FIGURE 51. UNITED STATES BIOCHIPS MARKET SIZE, BY GENOMICS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 52. UNITED STATES BIOCHIPS MARKET SIZE, BY HIGH-THROUGHPUT SCREENING, 2018-2026 (USD MILLION)
FIGURE 53. UNITED STATES BIOCHIPS MARKET SIZE, BY HIGH-THROUGHPUT SCREENING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 54. UNITED STATES BIOCHIPS MARKET SIZE, BY IVD & POC, 2018-2026 (USD MILLION)
FIGURE 55. UNITED STATES BIOCHIPS MARKET SIZE, BY IVD & POC, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 56. UNITED STATES BIOCHIPS MARKET SIZE, BY PROTEOMICS, 2018-2026 (USD MILLION)
FIGURE 57. UNITED STATES BIOCHIPS MARKET SIZE, BY PROTEOMICS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 58. UNITED STATES BIOCHIPS MARKET SIZE, BY SNP GENOTYPING, 2018-2026 (USD MILLION)
FIGURE 59. UNITED STATES BIOCHIPS MARKET SIZE, BY SNP GENOTYPING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 60. UNITED STATES BIOCHIPS MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 61. UNITED STATES BIOCHIPS MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 62. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES BIOCHIPS MARKET SIZE, BY END USER, 2026
FIGURE 63. UNITED STATES BIOCHIPS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2026 (USD MILLION)
FIGURE 64. UNITED STATES BIOCHIPS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 65. UNITED STATES BIOCHIPS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, 2018-2026 (USD MILLION)
FIGURE 66. UNITED STATES BIOCHIPS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 67. UNITED STATES BIOCHIPS MARKET SIZE, BY HOSPITALS & DIAGNOSTICS CENTERS, 2018-2026 (USD MILLION)
FIGURE 68. UNITED STATES BIOCHIPS MARKET SIZE, BY HOSPITALS & DIAGNOSTICS CENTERS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 69. CALIFORNIA BIOCHIPS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 70. FLORIDA BIOCHIPS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 71. ILLINOIS BIOCHIPS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 72. NEW YORK BIOCHIPS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 73. OHIO BIOCHIPS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 74. PENNSYLVANIA BIOCHIPS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 75. TEXAS BIOCHIPS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 76. UNITED STATES BIOCHIPS MARKET: FPNV POSITIONING MATRIX
FIGURE 77. UNITED STATES BIOCHIPS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 78. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES BIOCHIPS MARKET, BY TYPE

List of Tables
TABLE 1. UNITED STATES BIOCHIPS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. UNITED STATES BIOCHIPS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. UNITED STATES BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2026 (USD MILLION)
TABLE 5. UNITED STATES BIOCHIPS MARKET SIZE, BY MICROARRAYS, BY STATE, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES BIOCHIPS MARKET SIZE, BY MICROFLUIDICS, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. UNITED STATES BIOCHIPS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 8. UNITED STATES BIOCHIPS MARKET SIZE, BY ARRAYS, BY STATE, 2018-2026 (USD MILLION)
TABLE 9. UNITED STATES BIOCHIPS MARKET SIZE, BY CELL ARRAYS, BY STATE, 2018-2026 (USD MILLION)
TABLE 10. UNITED STATES BIOCHIPS MARKET SIZE, BY TISSUE ARRAYS, BY STATE, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES BIOCHIPS MARKET SIZE, BY DNA CHIPS, BY STATE, 2018-2026 (USD MILLION)
TABLE 12. UNITED STATES BIOCHIPS MARKET SIZE, BY LAB-ON-A-CHIP, BY STATE, 2018-2026 (USD MILLION)
TABLE 13. UNITED STATES BIOCHIPS MARKET SIZE, BY PROTEIN CHIPS, BY STATE, 2018-2026 (USD MILLION)
TABLE 14. UNITED STATES BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 15. UNITED STATES BIOCHIPS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY STATE, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES BIOCHIPS MARKET SIZE, BY CANCER DIAGNOSIS & TREATMENT, BY STATE, 2018-2026 (USD MILLION)
TABLE 17. UNITED STATES BIOCHIPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY STATE, 2018-2026 (USD MILLION)
TABLE 18. UNITED STATES BIOCHIPS MARKET SIZE, BY DNA CHIP APPLICATIONS, BY STATE, 2018-2026 (USD MILLION)
TABLE 19. UNITED STATES BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, BY STATE, 2018-2026 (USD MILLION)
TABLE 20. UNITED STATES BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, BY STATE, 2018-2026 (USD MILLION)
TABLE 21. UNITED STATES BIOCHIPS MARKET SIZE, BY EXPRESSION PROFILING, BY STATE, 2018-2026 (USD MILLION)
TABLE 22. UNITED STATES BIOCHIPS MARKET SIZE, BY GENE EXPRESSION, BY STATE, 2018-2026 (USD MILLION)
TABLE 23. UNITED STATES BIOCHIPS MARKET SIZE, BY GENOMICS, BY STATE, 2018-2026 (USD MILLION)
TABLE 24. UNITED STATES BIOCHIPS MARKET SIZE, BY HIGH-THROUGHPUT SCREENING, BY STATE, 2018-2026 (USD MILLION)
TABLE 25. UNITED STATES BIOCHIPS MARKET SIZE, BY IVD & POC, BY STATE, 2018-2026 (USD MILLION)
TABLE 26. UNITED STATES BIOCHIPS MARKET SIZE, BY PROTEOMICS, BY STATE, 2018-2026 (USD MILLION)
TABLE 27. UNITED STATES BIOCHIPS MARKET SIZE, BY SNP GENOTYPING, BY STATE, 2018-2026 (USD MILLION)
TABLE 28. UNITED STATES BIOCHIPS MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 29. UNITED STATES BIOCHIPS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY STATE, 2018-2026 (USD MILLION)
TABLE 30. UNITED STATES BIOCHIPS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 31. UNITED STATES BIOCHIPS MARKET SIZE, BY HOSPITALS & DIAGNOSTICS CENTERS, BY STATE, 2018-2026 (USD MILLION)
TABLE 32. CALIFORNIA BIOCHIPS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. FLORIDA BIOCHIPS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. ILLINOIS BIOCHIPS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. NEW YORK BIOCHIPS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. OHIO BIOCHIPS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. PENNSYLVANIA BIOCHIPS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. TEXAS BIOCHIPS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. UNITED STATES BIOCHIPS MARKET: SCORES
TABLE 40. UNITED STATES BIOCHIPS MARKET: BUSINESS STRATEGY
TABLE 41. UNITED STATES BIOCHIPS MARKET: PRODUCT SATISFACTION
TABLE 42. UNITED STATES BIOCHIPS MARKET: RANKING
TABLE 43. UNITED STATES BIOCHIPS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 44. UNITED STATES BIOCHIPS MARKET: MERGER & ACQUISITION
TABLE 45. UNITED STATES BIOCHIPS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 46. UNITED STATES BIOCHIPS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 47. UNITED STATES BIOCHIPS MARKET: INVESTMENT & FUNDING
TABLE 48. UNITED STATES BIOCHIPS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 49. UNITED STATES BIOCHIPS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll